Serum Biomarkers for Chronic Renal Failure Screening and Mechanistic Understanding: A Global LC-MS-Based Metabolomics Research

Table 2

Sample characteristics of the RF.

	Characteristics	RF
	BMI (kg/m^2)	23.07 ± 3.72
Liver function	ALT (U/L)	12.14 ± 8.62
	AST (U/L)	13.33 ± 6.26
	AST/ALT	1.47 ± 0.84
Renal function	Ur	20.33 ± 5.23
	Cr (μmol/L)	937.10 ± 250.72
	Scr (mg/dl)	10.60 ± 2.84
	eGFR (mL/min/1.73 m^2	5.35 ± 1.81
	UA (μmol/L)	442.58 ± 111.41
Blood glucose	GLU (mmol/L)	7.57 ± 5.39
Blood lipids	TG (mmol/L)	1.98 ± 1.62
	TC (mmol/L)	3.15 ± 0.63
	HDL-C (mmol/L)	1.01 ± 0.36
	LDL-C (mmol/L)	2.38 ± 0.589
Past medical history	Treat/Not treat	RF
Coronary heart disease	Treated	13 (48.14%)
Diabetes	Treated	5 (18.52%)
Renal hypertension	Treated	11 (40.74)
No disease		3 (11.11%)